A comparative study of Salbutamol and levosalbutamol nebulisation in Acute Bronchial Asthma in children

Comparison of Levosalbutamol and Salbutamol nebulisation in Acute Bronchial Asthma in children - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/08/001931

Enrollment

Registered

2011-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute Bronchial Asthma

Interventions

Intervention1: Levosalbutamol Nebulisation: Three doses of Levosalbutamol, At an interval of 20 minutes, Dose 0.04mg/kg/dose, By Nebulisation Control Intervention1: Salbutamol Nebulisation: Three dose

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Acute Bronchial Asthma in age group of 3 to 12 years age

Exclusion criteria

Exclusion criteria: 1) Patients of Pneumonia 2) Presence of Congenital Heart Disease 3) Patients with suspected foreign body aspiration 4) Very sick patients with co morbid conditions as Seizures, Shock, Congestive HHeart Failure

Design outcomes

Primary

Measure	Time frame
1) Improvement in Respiratory rate, Asthma Score, Oxygen saturation 2) Admission rateTimepoint: At the time of enrollment and half an hour after 3rd nebulisation	—

Secondary

Measure	Time frame
Appearance of side effects as Tachycardia, tremors, nausea, headacheTimepoint: After 3 nebulisations	—

Countries

India

Contacts

Public ContactDr Neeraj Dhawan

doctor.kanwar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026